{"id":20144,"date":"2015-07-08T10:52:02","date_gmt":"2015-07-08T08:52:02","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=20144"},"modified":"2015-07-08T10:52:02","modified_gmt":"2015-07-08T08:52:02","slug":"farmaceutico-teva-ci-riprova-con-mylan-verso-rialzo-offerta-fino-almeno-a-43-mld","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/farmaceutico-teva-ci-riprova-con-mylan-verso-rialzo-offerta-fino-almeno-a-43-mld\/","title":{"rendered":"Pharmaceutical: Teva tries again with Mylan, offer increases to at least 43 billion $"},"content":{"rendered":"

\"\"(Il Sole 24 Ore Radiocor) \u2013 New York, 07 July \u2013 Whether Mylan will change his mind remains to be seen. So far, the group has strongly opposed the takeover as it unsuccessfully attempted to buy Perrigo, another generics maker, in an unwelcome move.<\/p>\n

Teva's advances are complicated by the fact that Mylan has been based in the Netherlands since last year it acquired the foreign assets of US rival Abbott Laboratories in a "tax inversion" deal.<\/p>\n

With the stake in Mylan raked up last month, Teva is for the first time able to present a formal takeover proposal based on Dutch law. But there are other legal hurdles to overcome. In the pre-market, Teva rose by half a percentage point, Mylan by 0.9% to 71.4 dollars.<\/p>\n

A24-Spa<\/p>\n

(RADIOCOR) 07-07-15 13:53:15 (0355) 5 NNNN<\/p>\n

Borsa Italiana \u2013 7 July 2015<\/span><\/a><\/p>","protected":false},"excerpt":{"rendered":"

(Il Sole 24 Ore Radiocor) – New York, 07 lug – Resta da vedere se Mylan cambiera’ idea. Fino ad ora il gruppo si e’ opposto fortemente al takeover mentre tentava a sua volta – senza successo – di comprare con una mossa indesiderata Perrigo, un altro produttore di farmaci generici. Le avance di Teva …<\/p>","protected":false},"author":4,"featured_media":9777,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[53],"class_list":["post-20144","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-fusioniacquisizioni"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/20144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=20144"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/20144\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9777"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=20144"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=20144"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=20144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}